Multiple early factors anticipate post-acute COVID-19 sequelae
2022 · Cell · 1,156 citations
https://doi.org/10.1016/j.cell.2022.01.014
J
James R. Heath
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
603
Papers
51.8K
Citations
108
h-index
312
i10-index
James R. Heath is an academic researcher from California Institute of Technology. The author has contributed to research in topics: Molecular Junctions and Nanostructures & Immunotherapy and Immune Responses & CAR-T cell therapy research. The author has an h-index of 108, co-authored 513 publications.
ORCID: 0000-0001-5356-4385Papers by this author
worksSystems Biology and New Technologies Enable Predictive and Preventative Medicine
2004 · Science · 1,104 citations
https://doi.org/10.1126/science.1104635
Thermodynamic Control of Gold Nanocrystal Size: Experiment and Theory
1995 · The Journal of Physical Chemistry · 652 citations
https://doi.org/10.1021/j100018a041
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
2021 · Science Immunology · 617 citations
https://doi.org/10.1126/sciimmunol.abl4340
Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL
2018 · Blood · 334 citations
https://doi.org/10.1182/blood-2018-01-828343
Non-viral precision T cell receptor replacement for personalized cell therapy
2022 · Nature · 252 citations
https://doi.org/10.1038/s41586-022-05531-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat